Inhaled Insulin to Treat Diabetes Earns FDA Committee Recommendation
The inhaled insulin Afrezza has been recommended for approval by a Food and Drug Administration (FDA) advisory committee. The drug,
Read MoreThe inhaled insulin Afrezza has been recommended for approval by a Food and Drug Administration (FDA) advisory committee. The drug,
Read MoreIsrael-based Oramed announced that it has sent an application to the Food and Drug Administration for permission to enter Phase
Read MoreThe latest clinical guidelines for treating type 2 diabetes from the American College of Physicians (ACP) indicate that when diet,
Read MoreAfter several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The
Read More